Skip to main content
Clinical Trials/JPRN-UMIN000006344
JPRN-UMIN000006344
Not yet recruiting
Phase 4

Evaluation of abdominal symptoms and gastrointestinal mucosal injuries in patients receiving oral anticoagulant dabigatran - Evaluation of abdominal symptoms and gastrointestinal mucosal injuries in patients receiving oral anticoagulant dabigatran

Kobe University Hospital0 sites50 target enrollmentSeptember 14, 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
pper gastrointestinal mucosal injury
Sponsor
Kobe University Hospital
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2011
End Date
May 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a. Patients with severe renal failure including those on hemodialysis (creatinine clearance of less than 30mL/min) b. Patients having organic lesions with a risk of bleeding (within 6 months after the onset of hemorrhagic stroke) c. Patients with a spinal/epidural catheter inserted or those in which the spinal/epidural catheter was just removed within 1 hour d. Patients with a history of hypersensitivity for tabeprazole, famotidine, or rebamipide e. Patients who are taking itraconazole f. Patients judged by investigators as ineligible for study enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials